Aclaris Therapeutics, Inc. (ACRS) Ownership

$1.53

$0.04 (-2.55%)
Last update: 04:00 PM EST
Day's range
$1.52
Day's range
$1.57

Aclaris Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BML CAPITAL MANAGEMENT, LLC 05/07/2025 14.25 M $21.80 M   0.00% 11.64%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 9.63 M $14.73 M   0.00% 7.87%
VIVO CAPITAL, LLC 05/12/2025 8.89 M $13.60 M   0.00% 7.26%
VANGUARD GROUP INC 05/09/2025 4.97 M $7.60 M   14.91% 4.06%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 4.67 M $7.14 M   0.00% 3.81%
MILLENNIUM MANAGEMENT LLC 05/15/2025 4.13 M $6.33 M   111.03% 3.38%
DECHENG CAPITAL LLC 05/08/2025 4.04 M $6.18 M   78.31% 3.30%
D. E. SHAW & CO., INC. 05/15/2025 2.94 M $4.51 M   -10.60% 2.41%
MORGAN STANLEY 05/15/2025 2.42 M $3.70 M   125.38% 1.97%
MARSHALL WACE, LLP 05/15/2025 2.31 M $3.54 M   -12.19% 1.89%
ACADIAN ASSET MANAGEMENT LLC 05/21/2025 2.20 M $3.36 M   25.86% 1.79%
BOLLARD GROUP LLC 05/15/2025 1.42 M $2.18 M   100.00% 1.16%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 1.38 M $2.11 M   1,648.00% 1.13%
BLACKROCK, INC. 05/02/2025 1.36 M $2.08 M   8.21% 1.11%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2025 1.35 M $2.07 M   119.62% 1.10%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.18 M $1.81 M   49.79% 0.97%
CITADEL ADVISORS LLC 05/15/2025 1.12 M $1.72 M   1,927.36% 0.92%
ALDEBARAN CAPITAL, LLC 05/13/2025 1.01 M $1.54 M   -0.89% 0.82%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 951.39 K $1.46 M   11.86% 0.78%
DEUTSCHE BANK AG\ 05/09/2025 923.31 K $1.41 M   0.00% 0.75%
MONASHEE INVESTMENT MANAGEMENT LLC 05/14/2025 888.89 K $1.36 M   0.00% 0.73%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/12/2025 865.01 K $1.32 M   -4.82% 0.71%
TWO SIGMA ADVISERS, LP 05/15/2025 858.40 K $1.31 M   -12.18% 0.70%
TWO SIGMA INVESTMENTS, LP 05/15/2025 820.26 K $1.26 M   -2.26% 0.67%
PALO ALTO INVESTORS LP 05/15/2025 776.03 K $1.19 M   36.19% 0.63%
CANTOR FITZGERALD, L. P. 05/15/2025 695.57 K $1.06 M   595.57% 0.57%
ASSENAGON ASSET MANAGEMENT S.A. 04/15/2025 681.55 K $1.04 M   71.52% 0.56%
GOLDMAN SACHS GROUP INC 05/16/2025 555.95 K $850.61 K   29.72% 0.45%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2025 527.84 K $2.77 M   -20.43% 0.43%
JPMORGAN CHASE & CO 05/12/2025 498.72 K $763.04 K   464.68% 0.41%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2025 460.84 K $705.09 K   -20.00% 0.38%
FMR LLC 05/12/2025 458.18 K $701.02 K   -0.19% 0.37%
AISLING CAPITAL MANAGEMENT LP 05/13/2025 434.46 K $664.72 K   0.00% 0.36%
STATE STREET CORP 05/15/2025 407.53 K $623.51 K   27.64% 0.33%
JANE STREET GROUP, LLC 05/19/2025 390.28 K $597.13 K   -28.46% 0.32%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 354.85 K $543.26 K   48.10% 0.29%
SQUAREPOINT OPS LLC 05/15/2025 348.92 K $533.84 K   19.13% 0.29%
HIGHTOWER ADVISORS, LLC 05/13/2025 316.06 K $483.58 K   20.20% 0.26%
WALLEYE CAPITAL LLC 05/14/2025 311.71 K $476.92 K   -56.64% 0.25%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 288.72 K $441.74 K   2.70% 0.24%
NORTHERN TRUST CORP 05/13/2025 269.09 K $411.70 K   53.61% 0.22%
RAYMOND JAMES FINANCIAL INC 05/13/2025 250.81 K $383.73 K   62.49% 0.20%
MAN GROUP PLC 05/15/2025 197.75 K $302.55 K   269.39% 0.16%
GRAHAM CAPITAL MANAGEMENT, L.P. 05/15/2025 177.56 K $271.66 K   1,152.88% 0.15%
OMERS ADMINISTRATION CORP 05/14/2025 175.90 K $269.13 K   223.35% 0.14%
BANK OF AMERICA CORP /DE/ 05/15/2025 167.67 K $256.53 K   -18.40% 0.14%
IKARIAN CAPITAL, LLC 05/15/2025 150.90 K $230.88 K   -56.89% 0.12%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 127.59 K $195.22 K   -3.26% 0.10%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 123.10 K $189.00 K   0.00% 0.10%
BARCLAYS PLC 05/15/2025 119.00 K $182.00 K   682.85% 0.10%

Aclaris Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 142 institutional investors and hedge funds held shares of Aclaris Therapeutics, Inc.. The most heavily invested institutionals were:

BML Capital Management, LLC: 14.25 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 9.63 M

Vivo Capital, LLC: 8.89 M

VANGUARD GROUP INC: 4.97 M

RA CAPITAL MANAGEMENT, L.P.: 4.67 M

MILLENNIUM MANAGEMENT LLC: 4.13 M

75.74% of Aclaris Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 92.44 M shares in the last 24 months. This purchase volume represents approximately $141.43 M in transactions.